Circulating tumor cells (CTCs) are rare (few cells per milliliter of blood) and mostly isolated
as single cell CTCs (scCTCs). CTC clusters (cCTCs), even rarer, are of growing interest …

Background The presence of circulating tumor cells (CTCs) in blood is correlated with
disease progression in many cancers. Their prognosis value in ovarian cancer is still under …

Extremely rare circulating tumor cell (CTC) clusters are both increasingly appreciated as
highly metastatic precursors and virtually unexplored. Technologies are primarily designed …

Blood-borne metastasis accounts for most cancer-related deaths and involves circulating
tumor cells (CTCs) that are successful in establishing new tumors at distant sites. CTCs are …

Circulating tumor cells (CTCs) enter the vasculature from solid tumors and disseminate
widely to initiate metastases. Mining the metastatic-enriched molecular signatures of CTCs …

Circulating tumor cells (CTCs) are shed from solid cancers in the form of single or clustered
cells, and the latter display an extraordinary ability to initiate metastasis. Yet, the biological …

The major cause of cancer-associated mortality is tumor metastasis, a disease that is far
from understood. Many studies have observed circulating tumor cells (CTCs) in patients' …

Circulating tumor cells (CTCs) are vital components of liquid biopsies for diagnosis of
residual cancer, monitoring of therapy response, and prognosis of recurrence. Scientific …

Multimodal analysis of circulating tumour cells (CTCs) has the potential to provide
remarkable insight for cancer development and metastasis. CTCs and CTC clusters …

Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases,
which are ultimately responsible for most cancer deaths. Technologies that allow for …